Global Genome Editing and Genome Engineering Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Genome Editing and Genome Engineering Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 94

Published Date: 22 Nov 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Genome Editing and Genome Engineering market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Genome Editing and Genome Engineering size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Genome Editing and Genome Engineering market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Genome Editing and Genome Engineering market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
CRISPR
TALEN
ZFN

Market segment by Application, can be divided into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others

Market segment by players, this report covers
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genome Editing and Genome Engineering product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genome Editing and Genome Engineering, with revenue, gross margin and global market share of Genome Editing and Genome Engineering from 2019 to 2021.
Chapter 3, the Genome Editing and Genome Engineering competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Genome Editing and Genome Engineering market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Genome Editing and Genome Engineering research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Genome Editing and Genome Engineering
1.2 Classification of Genome Editing and Genome Engineering by Type
1.2.1 Overview: Global Genome Editing and Genome Engineering Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Genome Editing and Genome Engineering Revenue Market Share by Type in 2020
1.2.3 CRISPR
1.2.4 TALEN
1.2.5 ZFN
1.3 Global Genome Editing and Genome Engineering Market by Application
1.3.1 Overview: Global Genome Editing and Genome Engineering Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.3.5 Others
1.4 Global Genome Editing and Genome Engineering Market Size & Forecast
1.5 Global Genome Editing and Genome Engineering Market Size and Forecast by Region
1.5.1 Global Genome Editing and Genome Engineering Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Genome Editing and Genome Engineering Market Size by Region, (2016-2021)
1.5.3 North America Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.4 Europe Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.6 South America Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genome Editing and Genome Engineering Market Drivers
1.6.2 Genome Editing and Genome Engineering Market Restraints
1.6.3 Genome Editing and Genome Engineering Trends Analysis

2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Product and Solutions
2.1.4 Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Genome Editing and Genome Engineering Product and Solutions
2.2.4 Merck Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Horizon Discovery
2.3.1 Horizon Discovery Details
2.3.2 Horizon Discovery Major Business
2.3.3 Horizon Discovery Genome Editing and Genome Engineering Product and Solutions
2.3.4 Horizon Discovery Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Horizon Discovery Recent Developments and Future Plans
2.4 Genscript
2.4.1 Genscript Details
2.4.2 Genscript Major Business
2.4.3 Genscript Genome Editing and Genome Engineering Product and Solutions
2.4.4 Genscript Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Genscript Recent Developments and Future Plans
2.5 Sangamo Biosciences
2.5.1 Sangamo Biosciences Details
2.5.2 Sangamo Biosciences Major Business
2.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Product and Solutions
2.5.4 Sangamo Biosciences Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sangamo Biosciences Recent Developments and Future Plans
2.6 Integrated DNA Technologies
2.6.1 Integrated DNA Technologies Details
2.6.2 Integrated DNA Technologies Major Business
2.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Product and Solutions
2.6.4 Integrated DNA Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Integrated DNA Technologies Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Genome Editing and Genome Engineering Product and Solutions
2.7.4 Lonza Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Lonza Recent Developments and Future Plans
2.8 New England Biolabs
2.8.1 New England Biolabs Details
2.8.2 New England Biolabs Major Business
2.8.3 New England Biolabs Genome Editing and Genome Engineering Product and Solutions
2.8.4 New England Biolabs Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 New England Biolabs Recent Developments and Future Plans
2.9 Origene Technologies
2.9.1 Origene Technologies Details
2.9.2 Origene Technologies Major Business
2.9.3 Origene Technologies Genome Editing and Genome Engineering Product and Solutions
2.9.4 Origene Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Origene Technologies Recent Developments and Future Plans
2.10 Transposagen Biopharmaceuticals
2.10.1 Transposagen Biopharmaceuticals Details
2.10.2 Transposagen Biopharmaceuticals Major Business
2.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product and Solutions
2.10.4 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.11 Editas Medicine
2.11.1 Editas Medicine Details
2.11.2 Editas Medicine Major Business
2.11.3 Editas Medicine Genome Editing and Genome Engineering Product and Solutions
2.11.4 Editas Medicine Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Editas Medicine Recent Developments and Future Plans
2.12 Crispr Therapeutics
2.12.1 Crispr Therapeutics Details
2.12.2 Crispr Therapeutics Major Business
2.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Product and Solutions
2.12.4 Crispr Therapeutics Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Crispr Therapeutics Recent Developments and Future Plans
2.13 Tecan Life Sciences
2.13.1 Tecan Life Sciences Details
2.13.2 Tecan Life Sciences Major Business
2.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Product and Solutions
2.13.4 Tecan Life Sciences Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Tecan Life Sciences Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Genome Editing and Genome Engineering Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Genome Editing and Genome Engineering Players Market Share
3.2.2 Top 10 Genome Editing and Genome Engineering Players Market Share
3.2.3 Market Competition Trend
3.3 Genome Editing and Genome Engineering Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Genome Editing and Genome Engineering Revenue and Market Share by Type (2016-2021)
4.2 Global Genome Editing and Genome Engineering Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Genome Editing and Genome Engineering Revenue Market Share by Application (2016-2021)
5.2 Genome Editing and Genome Engineering Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Genome Editing and Genome Engineering Revenue by Type (2016-2026)
6.2 North America Genome Editing and Genome Engineering Revenue by Application (2016-2026)
6.3 North America Genome Editing and Genome Engineering Market Size by Country
6.3.1 North America Genome Editing and Genome Engineering Revenue by Country (2016-2026)
6.3.2 United States Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
6.3.3 Canada Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
6.3.4 Mexico Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Genome Editing and Genome Engineering Revenue by Type (2016-2026)
7.2 Europe Genome Editing and Genome Engineering Revenue by Application (2016-2026)
7.3 Europe Genome Editing and Genome Engineering Market Size by Country
7.3.1 Europe Genome Editing and Genome Engineering Revenue by Country (2016-2026)
7.3.2 Germany Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.3 France Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.5 Russia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.6 Italy Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genome Editing and Genome Engineering Revenue by Type (2016-2026)
8.2 Asia-Pacific Genome Editing and Genome Engineering Revenue by Application (2016-2026)
8.3 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region
8.3.1 Asia-Pacific Genome Editing and Genome Engineering Revenue by Region (2016-2026)
8.3.2 China Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.3 Japan Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.4 South Korea Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.5 India Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.7 Australia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Genome Editing and Genome Engineering Revenue by Type (2016-2026)
9.2 South America Genome Editing and Genome Engineering Revenue by Application (2016-2026)
9.3 South America Genome Editing and Genome Engineering Market Size by Country
9.3.1 South America Genome Editing and Genome Engineering Revenue by Country (2016-2026)
9.3.2 Brazil Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
9.3.3 Argentina Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genome Editing and Genome Engineering Revenue by Type (2016-2026)
10.2 Middle East & Africa Genome Editing and Genome Engineering Revenue by Application (2016-2026)
10.3 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country
10.3.1 Middle East & Africa Genome Editing and Genome Engineering Revenue by Country (2016-2026)
10.3.2 Turkey Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
10.3.4 UAE Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Genome Editing and Genome Engineering Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Genome Editing and Genome Engineering Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Genome Editing and Genome Engineering Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Genome Editing and Genome Engineering Revenue (USD Million) by Region (2016-2021)
Table 5. Global Genome Editing and Genome Engineering Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Genome Editing and Genome Engineering Product and Solutions
Table 9. Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Genome Editing and Genome Engineering Product and Solutions
Table 13. Merck Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 15. Horizon Discovery Major Business
Table 16. Horizon Discovery Genome Editing and Genome Engineering Product and Solutions
Table 17. Horizon Discovery Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Genscript Corporate Information, Head Office, and Major Competitors
Table 19. Genscript Major Business
Table 20. Genscript Genome Editing and Genome Engineering Product and Solutions
Table 21. Genscript Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sangamo Biosciences Corporate Information, Head Office, and Major Competitors
Table 23. Sangamo Biosciences Major Business
Table 24. Sangamo Biosciences Genome Editing and Genome Engineering Product and Solutions
Table 25. Sangamo Biosciences Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 27. Integrated DNA Technologies Major Business
Table 28. Integrated DNA Technologies Genome Editing and Genome Engineering Product and Solutions
Table 29. Integrated DNA Technologies Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Lonza Corporate Information, Head Office, and Major Competitors
Table 31. Lonza Major Business
Table 32. Lonza Genome Editing and Genome Engineering Product and Solutions
Table 33. Lonza Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 35. New England Biolabs Major Business
Table 36. New England Biolabs Genome Editing and Genome Engineering Product and Solutions
Table 37. New England Biolabs Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Origene Technologies Corporate Information, Head Office, and Major Competitors
Table 39. Origene Technologies Major Business
Table 40. Origene Technologies Genome Editing and Genome Engineering Product and Solutions
Table 41. Origene Technologies Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Transposagen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Transposagen Biopharmaceuticals Major Business
Table 44. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product and Solutions
Table 45. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 47. Editas Medicine Major Business
Table 48. Editas Medicine Genome Editing and Genome Engineering Product and Solutions
Table 49. Editas Medicine Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Crispr Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Crispr Therapeutics Major Business
Table 52. Crispr Therapeutics Genome Editing and Genome Engineering Product and Solutions
Table 53. Crispr Therapeutics Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Tecan Life Sciences Corporate Information, Head Office, and Major Competitors
Table 55. Tecan Life Sciences Major Business
Table 56. Tecan Life Sciences Genome Editing and Genome Engineering Product and Solutions
Table 57. Tecan Life Sciences Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Genome Editing and Genome Engineering Revenue (USD Million) by Players (2019-2021)
Table 59. Global Genome Editing and Genome Engineering Revenue Share by Players (2019-2021)
Table 60. Breakdown of Genome Editing and Genome Engineering by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Genome Editing and Genome Engineering Players Head Office, Products and Services Provided
Table 62. Genome Editing and Genome Engineering Mergers & Acquisitions in the Past Five Years
Table 63. Genome Editing and Genome Engineering New Entrants and Expansion Plans
Table 64. Global Genome Editing and Genome Engineering Revenue (USD Million) by Type (2016-2021)
Table 65. Global Genome Editing and Genome Engineering Revenue Share by Type (2016-2021)
Table 66. Global Genome Editing and Genome Engineering Revenue Forecast by Type (2021-2026)
Table 67. Global Genome Editing and Genome Engineering Revenue by Application (2016-2021)
Table 68. Global Genome Editing and Genome Engineering Revenue Forecast by Application (2021-2026)
Table 69. North America Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Genome Editing and Genome Engineering Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Genome Editing and Genome Engineering Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Genome Editing and Genome Engineering Picture
Figure 2. Global Genome Editing and Genome Engineering Revenue Market Share by Type in 2020
Figure 3. CRISPR
Figure 4. TALEN
Figure 5. ZFN
Figure 6. Genome Editing and Genome Engineering Revenue Market Share by Application in 2020
Figure 7. Cell Line Engineering Picture
Figure 8. Animal Genetic Engineering Picture
Figure 9. Plant Genetic Engineering Picture
Figure 10. Others Picture
Figure 11. Global Genome Editing and Genome Engineering Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Genome Editing and Genome Engineering Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Genome Editing and Genome Engineering Revenue Market Share by Region (2016-2026)
Figure 14. Global Genome Editing and Genome Engineering Revenue Market Share by Region in 2020
Figure 15. North America Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Genome Editing and Genome Engineering Market Drivers
Figure 21. Genome Editing and Genome Engineering Market Restraints
Figure 22. Genome Editing and Genome Engineering Market Trends
Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Horizon Discovery Recent Developments and Future Plans
Figure 26. Genscript Recent Developments and Future Plans
Figure 27. Sangamo Biosciences Recent Developments and Future Plans
Figure 28. Integrated DNA Technologies Recent Developments and Future Plans
Figure 29. Lonza Recent Developments and Future Plans
Figure 30. New England Biolabs Recent Developments and Future Plans
Figure 31. Origene Technologies Recent Developments and Future Plans
Figure 32. Transposagen Biopharmaceuticals Recent Developments and Future Plans
Figure 33. Editas Medicine Recent Developments and Future Plans
Figure 34. Crispr Therapeutics Recent Developments and Future Plans
Figure 35. Tecan Life Sciences Recent Developments and Future Plans
Figure 36. Global Genome Editing and Genome Engineering Revenue Share by Players in 2020
Figure 37. Genome Editing and Genome Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Genome Editing and Genome Engineering Revenue Market Share in 2020
Figure 39. Global Top 10 Players Genome Editing and Genome Engineering Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Genome Editing and Genome Engineering Revenue Share by Type in 2020
Figure 42. Global Genome Editing and Genome Engineering Market Share Forecast by Type (2021-2026)
Figure 43. Global Genome Editing and Genome Engineering Revenue Share by Application in 2020
Figure 44. Global Genome Editing and Genome Engineering Market Share Forecast by Application (2021-2026)
Figure 45. North America Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 46. North America Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 47. North America Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 48. United States Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 52. Europe Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 53. Europe Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 54. Germany Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Genome Editing and Genome Engineering Revenue Market Share by Region (2016-2026)
Figure 62. China Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 69. South America Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 70. South America Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Genome Editing and Genome Engineering Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Genome Editing and Genome Engineering Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 94

Published Date: 22 Nov 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Genome Editing and Genome Engineering market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Genome Editing and Genome Engineering size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Genome Editing and Genome Engineering market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Genome Editing and Genome Engineering market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
CRISPR
TALEN
ZFN

Market segment by Application, can be divided into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others

Market segment by players, this report covers
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genome Editing and Genome Engineering product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genome Editing and Genome Engineering, with revenue, gross margin and global market share of Genome Editing and Genome Engineering from 2019 to 2021.
Chapter 3, the Genome Editing and Genome Engineering competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Genome Editing and Genome Engineering market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Genome Editing and Genome Engineering research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Genome Editing and Genome Engineering
1.2 Classification of Genome Editing and Genome Engineering by Type
1.2.1 Overview: Global Genome Editing and Genome Engineering Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Genome Editing and Genome Engineering Revenue Market Share by Type in 2020
1.2.3 CRISPR
1.2.4 TALEN
1.2.5 ZFN
1.3 Global Genome Editing and Genome Engineering Market by Application
1.3.1 Overview: Global Genome Editing and Genome Engineering Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.3.5 Others
1.4 Global Genome Editing and Genome Engineering Market Size & Forecast
1.5 Global Genome Editing and Genome Engineering Market Size and Forecast by Region
1.5.1 Global Genome Editing and Genome Engineering Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Genome Editing and Genome Engineering Market Size by Region, (2016-2021)
1.5.3 North America Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.4 Europe Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.6 South America Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Genome Editing and Genome Engineering Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genome Editing and Genome Engineering Market Drivers
1.6.2 Genome Editing and Genome Engineering Market Restraints
1.6.3 Genome Editing and Genome Engineering Trends Analysis

2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Product and Solutions
2.1.4 Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Genome Editing and Genome Engineering Product and Solutions
2.2.4 Merck Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Horizon Discovery
2.3.1 Horizon Discovery Details
2.3.2 Horizon Discovery Major Business
2.3.3 Horizon Discovery Genome Editing and Genome Engineering Product and Solutions
2.3.4 Horizon Discovery Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Horizon Discovery Recent Developments and Future Plans
2.4 Genscript
2.4.1 Genscript Details
2.4.2 Genscript Major Business
2.4.3 Genscript Genome Editing and Genome Engineering Product and Solutions
2.4.4 Genscript Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Genscript Recent Developments and Future Plans
2.5 Sangamo Biosciences
2.5.1 Sangamo Biosciences Details
2.5.2 Sangamo Biosciences Major Business
2.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Product and Solutions
2.5.4 Sangamo Biosciences Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sangamo Biosciences Recent Developments and Future Plans
2.6 Integrated DNA Technologies
2.6.1 Integrated DNA Technologies Details
2.6.2 Integrated DNA Technologies Major Business
2.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Product and Solutions
2.6.4 Integrated DNA Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Integrated DNA Technologies Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Genome Editing and Genome Engineering Product and Solutions
2.7.4 Lonza Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Lonza Recent Developments and Future Plans
2.8 New England Biolabs
2.8.1 New England Biolabs Details
2.8.2 New England Biolabs Major Business
2.8.3 New England Biolabs Genome Editing and Genome Engineering Product and Solutions
2.8.4 New England Biolabs Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 New England Biolabs Recent Developments and Future Plans
2.9 Origene Technologies
2.9.1 Origene Technologies Details
2.9.2 Origene Technologies Major Business
2.9.3 Origene Technologies Genome Editing and Genome Engineering Product and Solutions
2.9.4 Origene Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Origene Technologies Recent Developments and Future Plans
2.10 Transposagen Biopharmaceuticals
2.10.1 Transposagen Biopharmaceuticals Details
2.10.2 Transposagen Biopharmaceuticals Major Business
2.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product and Solutions
2.10.4 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.11 Editas Medicine
2.11.1 Editas Medicine Details
2.11.2 Editas Medicine Major Business
2.11.3 Editas Medicine Genome Editing and Genome Engineering Product and Solutions
2.11.4 Editas Medicine Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Editas Medicine Recent Developments and Future Plans
2.12 Crispr Therapeutics
2.12.1 Crispr Therapeutics Details
2.12.2 Crispr Therapeutics Major Business
2.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Product and Solutions
2.12.4 Crispr Therapeutics Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Crispr Therapeutics Recent Developments and Future Plans
2.13 Tecan Life Sciences
2.13.1 Tecan Life Sciences Details
2.13.2 Tecan Life Sciences Major Business
2.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Product and Solutions
2.13.4 Tecan Life Sciences Genome Editing and Genome Engineering Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Tecan Life Sciences Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Genome Editing and Genome Engineering Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Genome Editing and Genome Engineering Players Market Share
3.2.2 Top 10 Genome Editing and Genome Engineering Players Market Share
3.2.3 Market Competition Trend
3.3 Genome Editing and Genome Engineering Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Genome Editing and Genome Engineering Revenue and Market Share by Type (2016-2021)
4.2 Global Genome Editing and Genome Engineering Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Genome Editing and Genome Engineering Revenue Market Share by Application (2016-2021)
5.2 Genome Editing and Genome Engineering Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Genome Editing and Genome Engineering Revenue by Type (2016-2026)
6.2 North America Genome Editing and Genome Engineering Revenue by Application (2016-2026)
6.3 North America Genome Editing and Genome Engineering Market Size by Country
6.3.1 North America Genome Editing and Genome Engineering Revenue by Country (2016-2026)
6.3.2 United States Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
6.3.3 Canada Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
6.3.4 Mexico Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Genome Editing and Genome Engineering Revenue by Type (2016-2026)
7.2 Europe Genome Editing and Genome Engineering Revenue by Application (2016-2026)
7.3 Europe Genome Editing and Genome Engineering Market Size by Country
7.3.1 Europe Genome Editing and Genome Engineering Revenue by Country (2016-2026)
7.3.2 Germany Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.3 France Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.5 Russia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
7.3.6 Italy Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genome Editing and Genome Engineering Revenue by Type (2016-2026)
8.2 Asia-Pacific Genome Editing and Genome Engineering Revenue by Application (2016-2026)
8.3 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region
8.3.1 Asia-Pacific Genome Editing and Genome Engineering Revenue by Region (2016-2026)
8.3.2 China Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.3 Japan Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.4 South Korea Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.5 India Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
8.3.7 Australia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Genome Editing and Genome Engineering Revenue by Type (2016-2026)
9.2 South America Genome Editing and Genome Engineering Revenue by Application (2016-2026)
9.3 South America Genome Editing and Genome Engineering Market Size by Country
9.3.1 South America Genome Editing and Genome Engineering Revenue by Country (2016-2026)
9.3.2 Brazil Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
9.3.3 Argentina Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genome Editing and Genome Engineering Revenue by Type (2016-2026)
10.2 Middle East & Africa Genome Editing and Genome Engineering Revenue by Application (2016-2026)
10.3 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country
10.3.1 Middle East & Africa Genome Editing and Genome Engineering Revenue by Country (2016-2026)
10.3.2 Turkey Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)
10.3.4 UAE Genome Editing and Genome Engineering Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Genome Editing and Genome Engineering Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Genome Editing and Genome Engineering Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Genome Editing and Genome Engineering Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Genome Editing and Genome Engineering Revenue (USD Million) by Region (2016-2021)
Table 5. Global Genome Editing and Genome Engineering Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Genome Editing and Genome Engineering Product and Solutions
Table 9. Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Genome Editing and Genome Engineering Product and Solutions
Table 13. Merck Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 15. Horizon Discovery Major Business
Table 16. Horizon Discovery Genome Editing and Genome Engineering Product and Solutions
Table 17. Horizon Discovery Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Genscript Corporate Information, Head Office, and Major Competitors
Table 19. Genscript Major Business
Table 20. Genscript Genome Editing and Genome Engineering Product and Solutions
Table 21. Genscript Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sangamo Biosciences Corporate Information, Head Office, and Major Competitors
Table 23. Sangamo Biosciences Major Business
Table 24. Sangamo Biosciences Genome Editing and Genome Engineering Product and Solutions
Table 25. Sangamo Biosciences Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 27. Integrated DNA Technologies Major Business
Table 28. Integrated DNA Technologies Genome Editing and Genome Engineering Product and Solutions
Table 29. Integrated DNA Technologies Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Lonza Corporate Information, Head Office, and Major Competitors
Table 31. Lonza Major Business
Table 32. Lonza Genome Editing and Genome Engineering Product and Solutions
Table 33. Lonza Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 35. New England Biolabs Major Business
Table 36. New England Biolabs Genome Editing and Genome Engineering Product and Solutions
Table 37. New England Biolabs Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Origene Technologies Corporate Information, Head Office, and Major Competitors
Table 39. Origene Technologies Major Business
Table 40. Origene Technologies Genome Editing and Genome Engineering Product and Solutions
Table 41. Origene Technologies Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Transposagen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Transposagen Biopharmaceuticals Major Business
Table 44. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product and Solutions
Table 45. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 47. Editas Medicine Major Business
Table 48. Editas Medicine Genome Editing and Genome Engineering Product and Solutions
Table 49. Editas Medicine Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Crispr Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Crispr Therapeutics Major Business
Table 52. Crispr Therapeutics Genome Editing and Genome Engineering Product and Solutions
Table 53. Crispr Therapeutics Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Tecan Life Sciences Corporate Information, Head Office, and Major Competitors
Table 55. Tecan Life Sciences Major Business
Table 56. Tecan Life Sciences Genome Editing and Genome Engineering Product and Solutions
Table 57. Tecan Life Sciences Genome Editing and Genome Engineering Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Genome Editing and Genome Engineering Revenue (USD Million) by Players (2019-2021)
Table 59. Global Genome Editing and Genome Engineering Revenue Share by Players (2019-2021)
Table 60. Breakdown of Genome Editing and Genome Engineering by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Genome Editing and Genome Engineering Players Head Office, Products and Services Provided
Table 62. Genome Editing and Genome Engineering Mergers & Acquisitions in the Past Five Years
Table 63. Genome Editing and Genome Engineering New Entrants and Expansion Plans
Table 64. Global Genome Editing and Genome Engineering Revenue (USD Million) by Type (2016-2021)
Table 65. Global Genome Editing and Genome Engineering Revenue Share by Type (2016-2021)
Table 66. Global Genome Editing and Genome Engineering Revenue Forecast by Type (2021-2026)
Table 67. Global Genome Editing and Genome Engineering Revenue by Application (2016-2021)
Table 68. Global Genome Editing and Genome Engineering Revenue Forecast by Application (2021-2026)
Table 69. North America Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Genome Editing and Genome Engineering Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Genome Editing and Genome Engineering Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Genome Editing and Genome Engineering Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Genome Editing and Genome Engineering Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Genome Editing and Genome Engineering Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Genome Editing and Genome Engineering Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Genome Editing and Genome Engineering Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Genome Editing and Genome Engineering Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Genome Editing and Genome Engineering Picture
Figure 2. Global Genome Editing and Genome Engineering Revenue Market Share by Type in 2020
Figure 3. CRISPR
Figure 4. TALEN
Figure 5. ZFN
Figure 6. Genome Editing and Genome Engineering Revenue Market Share by Application in 2020
Figure 7. Cell Line Engineering Picture
Figure 8. Animal Genetic Engineering Picture
Figure 9. Plant Genetic Engineering Picture
Figure 10. Others Picture
Figure 11. Global Genome Editing and Genome Engineering Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Genome Editing and Genome Engineering Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Genome Editing and Genome Engineering Revenue Market Share by Region (2016-2026)
Figure 14. Global Genome Editing and Genome Engineering Revenue Market Share by Region in 2020
Figure 15. North America Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Genome Editing and Genome Engineering Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Genome Editing and Genome Engineering Market Drivers
Figure 21. Genome Editing and Genome Engineering Market Restraints
Figure 22. Genome Editing and Genome Engineering Market Trends
Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Horizon Discovery Recent Developments and Future Plans
Figure 26. Genscript Recent Developments and Future Plans
Figure 27. Sangamo Biosciences Recent Developments and Future Plans
Figure 28. Integrated DNA Technologies Recent Developments and Future Plans
Figure 29. Lonza Recent Developments and Future Plans
Figure 30. New England Biolabs Recent Developments and Future Plans
Figure 31. Origene Technologies Recent Developments and Future Plans
Figure 32. Transposagen Biopharmaceuticals Recent Developments and Future Plans
Figure 33. Editas Medicine Recent Developments and Future Plans
Figure 34. Crispr Therapeutics Recent Developments and Future Plans
Figure 35. Tecan Life Sciences Recent Developments and Future Plans
Figure 36. Global Genome Editing and Genome Engineering Revenue Share by Players in 2020
Figure 37. Genome Editing and Genome Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Genome Editing and Genome Engineering Revenue Market Share in 2020
Figure 39. Global Top 10 Players Genome Editing and Genome Engineering Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Genome Editing and Genome Engineering Revenue Share by Type in 2020
Figure 42. Global Genome Editing and Genome Engineering Market Share Forecast by Type (2021-2026)
Figure 43. Global Genome Editing and Genome Engineering Revenue Share by Application in 2020
Figure 44. Global Genome Editing and Genome Engineering Market Share Forecast by Application (2021-2026)
Figure 45. North America Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 46. North America Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 47. North America Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 48. United States Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 52. Europe Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 53. Europe Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 54. Germany Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Genome Editing and Genome Engineering Revenue Market Share by Region (2016-2026)
Figure 62. China Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 69. South America Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 70. South America Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Genome Editing and Genome Engineering Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Genome Editing and Genome Engineering Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Genome Editing and Genome Engineering Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Genome Editing and Genome Engineering Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
jiaGou

Add To Cart

gouMai

Buy Now